SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-001242
Filing Date
2018-02-02
Accepted
2018-02-02 09:30:20
Documents
7
Period of Report
2018-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20180202.htm 8-K 36118
2 EX-1.1 vktx-ex11_8.htm EX-1.1 282126
3 EX-5.1 vktx-ex51_7.htm EX-5.1 10538
4 EX-99.1 vktx-ex991_6.htm EX-99.1 15509
5 GRAPHIC g2018020214031511459307.jpg GRAPHIC 4119
6 GRAPHIC g201802021403160804111.jpg GRAPHIC 2494
7 GRAPHIC g201802021403161094112.jpg GRAPHIC 2494
  Complete submission text file 0001564590-18-001242.txt   358473
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 18568932
SIC: 2834 Pharmaceutical Preparations